• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.08% Nasdaq Up 0.24%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    11.98 Up 0.01(0.08%) 1:32PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:11.97
    Open:11.95
    Bid:11.98 x 300
    Ask:12.00 x 100
    1y Target Est:15.50
    Beta:1.36
    Earnings Date:Feb 9 - Feb 13 (Est.)
    Day's Range:11.78 - 12.07
    52wk Range:9.38 - 19.90
    Volume:233,378
    Avg Vol (3m):541,811
    Market Cap:618.05M
    P/E (ttm):N/A
    EPS (ttm):-2.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MNTA

    Comparison

    Symbol% ChgMkt Cap
    MNTAUp 0.08%618.05M
    GSKUp 0.14%104.21B
    SNYDown 1.32%121.21B
    TEVAUp 1.61%49.20B

    Key Statistics

    Forward P/E (1 yr):10.71
    P/S (ttm):14.09
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.71
    Quarterly EPS Est (Dec-14) :-0.16
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Momenta Pharmaceuticals, Inc., a biotechnology company, is engaged in the structural characterization, process engineering, and biologic systems analysis of complex molecules in the areas of complex generics, biosimilars, and novel drugs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback